MedPath

High Flow vs Conventional Oxygen in Head and Neck Surgery

Not Applicable
Completed
Conditions
Pulmonary Disease
COPD
Interventions
Device: HFOT using AIRVO2
Device: COT
Registration Number
NCT05362526
Lead Sponsor
University of Florida
Brief Summary

Patients undergoing major head and neck surgery are at risk for postoperative pulmonary complications. The goal of this randomized clinical trial is to evaluate the effectiveness of high flow heated humidified oxygen at preventing postoperative pulmonary complications after major head and neck surgery, when compared to conventional oxygen therapy (aerosol cool mist).

Detailed Description

Participants enrolled in this study are randomly assigned to receive either conventional oxygen therapy (aerosol cool mist) or heated humidified high flow oxygen via the trach after head and neck surgery. The study team then collects information regarding clinical outcomes to explore if there are differences between the two groups.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Patients undergoing major head and neck surgery that includes any neck dissection
  • Major head and neck surgery is defined as having a mean length of stay of three or more days, based on the diagnosis [14]
  • Surgery requires an elective tracheostomy for airway protection or laryngectomy tube in the case of total laryngectomy
Exclusion Criteria
  • <18 years of age

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
HFOT (High flow with tracheostomy interface)HFOT using AIRVO2Patient will be placed on heated humidified high flow after surgery.
COT (Conventional Oxygen Therapy)COTPt will be placed on conventional oxygen therapy after surgery.
Primary Outcome Measures
NameTimeMethod
Incidence of post-operative pulmonary complicationDay 14

Postoperative pulmonary complication will be defined as atelectasis or infiltrate diagnosed by radiologist on any postoperative chest radiograph within first 14 days or discharge (whichever occurs first)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Florida

🇺🇸

Jacksonville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath